Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 368

    1.

    Hematology: First-line bortezomib benefits patients with multiple myeloma.

    Dimopoulos MA, Terpos E.

    Nat Rev Clin Oncol. 2009 Dec;6(12):683-685. No abstract available. PMID: 19942924 [PubMed - as supplied by publisher]

    2.

    Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data.

    Mountzios G, Dimopoulos MA, Soria JC, Sanoudou D, Papadimitriou CA.

    Crit Rev Oncol Hematol. 2009 Nov 12. [Epub ahead of print]PMID: 19914087 [PubMed - as supplied by publisher]Related articles

    3.

    Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone.

    Zangari M, Tricot G, Polavaram L, Zhan F, Finlayson A, Knight R, Fu T, Weber D, Dimopoulos MA, Niesvizky R, Fink L.

    J Clin Oncol. 2009 Nov 9. [Epub ahead of print]PMID: 19901114 [PubMed - as supplied by publisher]Related articles

    4.

    Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer.

    Boskos CS, Liacos C, Korkolis D, Aygerinos K, Lamproglou I, Terpos E, Stoupa E, Baltatzis G, Beroukas K, Papasavvas P, Dimopoulos MA, Bamias A.

    J Surg Oncol. 2009 Oct 29. [Epub ahead of print]PMID: 19877119 [PubMed - as supplied by publisher]Related articles

    5.

    VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study.

    Dimopoulos MA, Richardson PG, Schlag R, Khuageva NK, Shpilberg O, Kastritis E, Kropff M, Petrucci MT, Delforge M, Alexeeva J, Schots R, Masszi T, Mateos MV, Deraedt W, Liu K, Cakana A, van de Velde H, San Miguel JF.

    J Clin Oncol. 2009 Oct 26. [Epub ahead of print]PMID: 19858394 [PubMed - as supplied by publisher]Related articles

    6.

    High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents.

    Terpos E, Dimopoulos MA, Shrivastava V, Leitzel K, Christoulas D, Migkou M, Gavriatopoulou M, Anargyrou K, Hamer P, Kastritis E, Carney W, Lipton A.

    Leuk Res. 2009 Sep 23. [Epub ahead of print]PMID: 19781774 [PubMed - as supplied by publisher]Related articles

    7.

    Clinicopathological features of primary fallopian tube carcinoma: a single institution experience.

    Papadimitriou CA, Markaki S, Lianos E, Peitsidis P, Vourli G, Nikitas N, Vlachos G, Rodolakis A, Antsaklis A, Dimopoulos MA.

    Eur J Gynaecol Oncol. 2009;30(4):389-95.PMID: 19761129 [PubMed - in process]Related articles

    8.

    Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.

    Savvari P, Peitsidis P, Alevizaki M, Dimopoulos MA, Antsaklis A, Papadimitriou CA.

    Onkologie. 2009 Sep;32(8-9):517-23. Epub 2009 Aug 12.PMID: 19745599 [PubMed - in process]Related articles

    9.

    Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma.

    Katodritou E, Dimopoulos MA, Zervas K, Terpos E.

    Cancer Treat Rev. 2009 Dec;35(8):738-43. Epub 2009 Sep 3.PMID: 19733008 [PubMed - in process]Related articles

    10.

    Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

    Papadimitriou CA, Kalofonos H, Zagouri F, Papakostas P, Bozas G, Makatsoris T, Dimopoulos MA, Fountzilas G.

    Oncology. 2009;77(3-4):212-6. Epub 2009 Sep 4.PMID: 19729979 [PubMed - indexed for MEDLINE]Related articles

    11.

    A new pet for myeloma.

    Dimopoulos MA, Moulopoulos LA, Terpos E.

    Blood. 2009 Sep 3;114(10):2007-8.PMID: 19729530 [PubMed]Related articles

    12.

    Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.

    Dimopoulos MA, Roussou M, Gavriatopoulou M, Zagouri F, Migkou M, Matsouka C, Barbarousi D, Christoulas D, Primenou E, Grapsa I, Terpos E, Kastritis E.

    Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6.PMID: 19717380 [PubMed - in process]Related articles

    13.

    Sunitinib treatment in patients with severe renal function impairment: a report of four cases by the Hellenic Cooperative Oncology Group.

    Lainakis G, Bamias A, Psimenou E, Fountzilas G, Dimopoulos MA.

    Clin Nephrol. 2009 Jul;72(1):73-8.PMID: 19640391 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.

    Dimopoulos MA, Chen C, Spencer A, Niesvizky R, Attal M, Stadtmauer EA, Petrucci MT, Yu Z, Olesnyckyj M, Zeldis JB, Knight RD, Weber DM.

    Leukemia. 2009 Nov;23(11):2147-52. Epub 2009 Jul 23.PMID: 19626046 [PubMed - in process]Related articles

    15.

    Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.

    Roussou M, Tasidou A, Dimopoulos MA, Kastritis E, Migkou M, Christoulas D, Gavriatopoulou M, Zagouri F, Matsouka C, Anagnostou D, Terpos E.

    Leukemia. 2009 Nov;23(11):2177-81. Epub 2009 Jul 9. No abstract available. PMID: 19587705 [PubMed - in process]Related articles

    16.

    Diagnosis and management of hypertension in advanced renal cell carcinoma: prospective evaluation of an algorithm in patients treated with sunitinib.

    Bamias A, Lainakis G, Manios E, Koroboki E, Gyftaki R, Zakopoulos N, Dimopoulos MA.

    J Chemother. 2009 Jun;21(3):347-50.PMID: 19567357 [PubMed - indexed for MEDLINE]Related articles

    17.

    International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

    Giralt S, Stadtmauer EA, Harousseau JL, Palumbo A, Bensinger W, Comenzo RL, Kumar S, Munshi NC, Dispenzieri A, Kyle R, Merlini G, San Miguel J, Ludwig H, Hajek R, Jagannath S, Blade J, Lonial S, Dimopoulos MA, Einsele H, Barlogie B, Anderson KC, Gertz M, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Richardson PG, Niesvizky R, Rajkumar SV, Durie BG; IMWG.

    Leukemia. 2009 Oct;23(10):1904-12. Epub 2009 Jun 25.PMID: 19554029 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental.

    Alevizaki M, Papageorgiou G, Rentziou G, Saltiki K, Marafelia P, Loukari E, Koutras DA, Dimopoulos MA.

    Thyroid. 2009 Jul;19(7):749-54.PMID: 19534620 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dickkopf-1: a suitable target for the management of myeloma bone disease.

    Gavriatopoulou M, Dimopoulos MA, Christoulas D, Migkou M, Iakovaki M, Gkotzamanidou M, Terpos E.

    Expert Opin Ther Targets. 2009 Jul;13(7):839-48. Review.PMID: 19530987 [PubMed - indexed for MEDLINE]Related articles

    20.

    International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.

    Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Bladé J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S; IMWG.

    Leukemia. 2009 Oct;23(10):1716-30. Epub 2009 Jun 4. Review.PMID: 19494840 [PubMed - indexed for MEDLINE]Related articles

    21.

    The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

    Terpos E, Sezer O, Croucher PI, García-Sanz R, Boccadoro M, San Miguel J, Ashcroft J, Bladé J, Cavo M, Delforge M, Dimopoulos MA, Facon T, Macro M, Waage A, Sonneveld P; European Myeloma Network.

    Ann Oncol. 2009 Aug;20(8):1303-17. Epub 2009 May 22. Review.PMID: 19465418 [PubMed - indexed for MEDLINE]Related articles

    22.

    Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

    Mountzios G, Dimopoulos MA, Bamias A, Vourli G, Kalofonos H, Aravantinos G, Fountzilas G, Papadimitriou CA.

    Ann Oncol. 2009 Aug;20(8):1362-8. Epub 2009 May 20.PMID: 19457937 [PubMed - indexed for MEDLINE]Related articles

    23.

    Association between transcriptional activity, local chromatin structure, and the efficiencies of both subpathways of nucleotide excision repair of melphalan adducts.

    Episkopou H, Kyrtopoulos SA, Sfikakis PP, Fousteri M, Dimopoulos MA, Mullenders LH, Souliotis VL.

    Cancer Res. 2009 May 15;69(10):4424-33. Epub 2009 May 5.PMID: 19417135 [PubMed - indexed for MEDLINE]Related articles

    24.

    Treatment of relapsed/refractory multiple myeloma.

    Kastritis E, Palumbo A, Dimopoulos MA.

    Semin Hematol. 2009 Apr;46(2):143-57. Review.PMID: 19389498 [PubMed - indexed for MEDLINE]Related articles

    25.

    Multiple myeloma in the era of novel agents.

    Dimopoulos MA, Attal M.

    Semin Hematol. 2009 Apr;46(2):107-9. No abstract available. PMID: 19389493 [PubMed - indexed for MEDLINE]Related articles

    26.

    Rituximab-based treatments in Waldenström's macroglobulinemia.

    Dimopoulos MA, Kastritis E, Roussou M, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Tassidou A, Terpos E.

    Clin Lymphoma Myeloma. 2009 Mar;9(1):59-61. Review.PMID: 19362975 [PubMed - indexed for MEDLINE]Related articles

    27.

    Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.

    Kastritis E, Zervas K, Repoussis P, Michali E, Katodrytou E, Zomas A, Simeonidis A, Terpos E, Delimbassi S, Vassou A, Gika D, Dimopoulos MA; Greek Myeloma Study Group.

    Clin Lymphoma Myeloma. 2009 Mar;9(1):50-2.PMID: 19362972 [PubMed - indexed for MEDLINE]Related articles

    28.

    Angiogenesis in Waldenström's macroglobulinemia.

    Terpos E, Tasidou A, Kastritis E, Eleftherakis-Papaiakovou E, Gavriatopoulou M, Migkou M, Dimopoulos MA.

    Clin Lymphoma Myeloma. 2009 Mar;9(1):46-9. Review.PMID: 19362971 [PubMed - indexed for MEDLINE]Related articles

    29.

    Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group.

    Bamias A, Aravantinos G, Kastriotis I, Alivizatos G, Anastasiou I, Christodoulou C, Gyftaki R, Kalofonos HP, Dimopoulos MA.

    Urol Oncol. 2009 Apr 10. [Epub ahead of print]PMID: 19362863 [PubMed - as supplied by publisher]Related articles

    30.

    RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.

    Terpos E, Efstathiou E, Christoulas D, Roussou M, Katodritou E, Dimopoulos MA.

    Expert Opin Biol Ther. 2009 Apr;9(4):465-79.PMID: 19344283 [PubMed - in process]Related articles

    31.

    Targeted therapies in multiple myeloma.

    Kastritis E, Charidimou A, Varkaris A, Dimopoulos MA.

    Target Oncol. 2009 Jan;4(1):23-36. Epub 2009 Jan 17. Review.PMID: 19343299 [PubMed - indexed for MEDLINE]Related articles

    32.

    Could rigorous diagnosis and management of hypertension reduce cardiac events in patients with renal cell carcinoma treated with tyrosine kinase inhibitors?

    Bamias A, Lainakis G, Manios E, Koroboki E, Karadimou A, Zakopoulos N, Dimopoulos MA.

    J Clin Oncol. 2009 May 20;27(15):2567-9; author reply 2569-70. Epub 2009 Mar 30. No abstract available. PMID: 19332708 [PubMed - indexed for MEDLINE]Related articles

    33.

    Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).

    Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Bamias A, Pavlidis N, Kalofonos HP, Timotheadou E, Samantas E, Briasoulis E, Skarlos DV, Economopoulos T, Dimopoulos MA; Hellenic Cooperative Oncology Group.

    Anticancer Res. 2009 Feb;29(2):745-51.PMID: 19331231 [PubMed - indexed for MEDLINE]Related articles

    34.

    Mitral valve prolapse in young healthy individuals. An early index of autoimmunity?

    Evangelopoulos ME, Toumanidis S, Sotou D, Evangelopoulos C, Mavrikakis M, Alevizaki M, Dimopoulos MA.

    Lupus. 2009 Apr;18(5):436-40.PMID: 19318397 [PubMed - indexed for MEDLINE]Related articles

    35.

    Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

    Stadtmauer EA, Weber DM, Niesvizky R, Belch A, Prince MH, San Miguel JF, Facon T, Olesnyckyj M, Yu Z, Zeldis JB, Knight RD, Dimopoulos MA.

    Eur J Haematol. 2009 Jun;82(6):426-32. Epub 2009 Mar 19.PMID: 19302559 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.

    Kountourakis P, Psyrri A, Scorilas A, Markakis S, Kowalski D, Camp RL, Diamandis EP, Dimopoulos MA.

    Thromb Haemost. 2009 Mar;101(3):541-6.PMID: 19277417 [PubMed - indexed for MEDLINE]Related articles

    37.

    Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.

    Terpos E, Katodritou E, Tsiftsakis E, Kastritis E, Christoulas D, Pouli A, Michalis E, Verrou E, Anargyrou K, Tsionos K, Dimopoulos MA, Zervas K; Greek Myeloma Study Group.

    Haematologica. 2009 Mar;94(3):372-9.PMID: 19252175 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Applications of monoclonal antibodies for the treatment of hematological malignancies.

    Migkou M, Dimopoulos MA, Gavriatopoulou M, Terpos E.

    Expert Opin Biol Ther. 2009 Feb;9(2):207-20. Review.PMID: 19236251 [PubMed - indexed for MEDLINE]Related articles

    39.

    Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

    Kastritis E, Zervas K, Symeonidis A, Terpos E, Delimbassi S, Anagnostopoulos N, Michali E, Zomas A, Katodritou E, Gika D, Pouli A, Christoulas D, Roussou M, Kartasis Z, Economopoulos T, Dimopoulos MA.

    Leukemia. 2009 Jun;23(6):1152-7. Epub 2009 Feb 19.PMID: 19225533 [PubMed - indexed for MEDLINE]Related articles

    40.

    Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo.

    Georgaki S, Skopeliti M, Tsiatas M, Nicolaou KA, Ioannou K, Husband A, Bamias A, Dimopoulos MA, Constantinou AI, Tsitsilonis OE.

    J Cell Mol Med. 2009 Feb 11. [Epub ahead of print]PMID: 19220577 [PubMed - as supplied by publisher]Related articles

    41.

    International prognostic scoring system for Waldenstrom macroglobulinemia.

    Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, Crowley J, Ocio EM, Garcia-Sanz R, Treon SP, Leblond V, Kyle RA, Barlogie B, Merlini G.

    Blood. 2009 Apr 30;113(18):4163-70. Epub 2009 Feb 5.PMID: 19196866 [PubMed - indexed for MEDLINE]Related articles

    42.

    Treatment of light chain deposition disease with bortezomib and dexamethasone.

    Kastritis E, Migkou M, Gavriatopoulou M, Zirogiannis P, Hadjikonstantinou V, Dimopoulos MA.

    Haematologica. 2009 Feb;94(2):300-2. Epub 2008 Dec 9. No abstract available. PMID: 19066331 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report.

    Kafantari E, Sotiropoulou M, Sfikakis P, Dimitrakakis K, Zagouri F, Mandrekas K, Dimopoulos S, Dimopoulos MA, Papadimitriou CA.

    Onkologie. 2008 Dec;31(12):685-8. Epub 2008 Nov 14.PMID: 19060507 [PubMed - indexed for MEDLINE]Related articles

    44.

    Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.

    Dimopoulos MA, Gertz MA, Kastritis E, Garcia-Sanz R, Kimby EK, Leblond V, Fermand JP, Merlini G, Morel P, Morra E, Ocio EM, Owen R, Ghobrial IM, Seymour J, Kyle RA, Treon SP.

    J Clin Oncol. 2009 Jan 1;27(1):120-6. Epub 2008 Dec 1. Review.PMID: 19047284 [PubMed - indexed for MEDLINE]Related articles

    45.

    Endocardial metastases as the only site of relapse in a patient with bladder carcinoma: A case report and review of the literature.

    Mountzios G, Bamias A, Dalianis A, Danias P, Pantelidaki E, Nanas J, Dimopoulos MA.

    Int J Cardiol. 2008 Nov 29. [Epub ahead of print]PMID: 19046610 [PubMed - as supplied by publisher]Related articles

    46.

    Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

    Koutras AK, Fountzilas G, Dafni U, Dimopoulos MA, Pectasides D, Klouvas G, Papakostas P, Kosmidis P, Samantas E, Gogas H, Briasoulis E, Vourli G, Petsas T, Xiros N, Kalofonos HP; Hellenic Cooperative Oncology Group.

    Anticancer Res. 2008 Sep-Oct;28(5B):2913-20.PMID: 19031934 [PubMed - indexed for MEDLINE]Related articles

    47.

    Natural history of osteonecrosis of the jaw in patients with multiple myeloma.

    Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E, Zervas K, Baer MR, Meiller T, Dimopoulos MA.

    J Clin Oncol. 2008 Dec 20;26(36):5904-9. Epub 2008 Nov 17.PMID: 19018084 [PubMed - indexed for MEDLINE]Related articles

    48.

    Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

    Koutras AK, Kalogeras KT, Dimopoulos MA, Wirtz RM, Dafni U, Briasoulis E, Pectasides D, Gogas H, Christodoulou C, Aravantinos G, Zografos G, Timotheadou E, Papakostas P, Linardou H, Razis E, Economopoulos T, Kalofonos HP, Fountzilas G; Hellenic Cooperative Oncology Group (HeCOG).

    Br J Cancer. 2008 Dec 2;99(11):1775-85. Epub 2008 Nov 4.PMID: 18985033 [PubMed - indexed for MEDLINE]Related articles

    49.

    Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).

    Kountourakis P, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA.

    Cancer Sci. 2008 Nov;99(11):2224-9. Epub 2008 Oct 9.PMID: 18957059 [PubMed - indexed for MEDLINE]Related articles

    50.

    Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication.

    Kastritis E, Murray S, Kyriakou F, Horti M, Tamvakis N, Kavantzas N, Patsouris ES, Noni A, Legaki S, Dimopoulos MA, Bamias A.

    Int J Cancer. 2009 Jan 1;124(1):103-8.PMID: 18844223 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...